A working group of clinicians and academics criticized the Cass Report for its methodological flaws and unsupported claims regarding transgender healthcare in England.
The report questioned the effectiveness of puberty-blocking hormones on gender dysphoria and criticized the World Professional Association of Transgender Healthcare for lacking developmental rigor.
[
add
]
[
|
|
...
]